Phase III Clinical Trials with 45,000 Participants in Arab Countries Show Efficacy of Sinopharm COVID-19 Vaccine is 78.89% on Adults

By Huang Lanlan

May 14, 2021 02:51 AM

Sinopharm vaccine File photo:VCG

File Photo:VCG

The ongoing Phase III clinical trials of one of China's Sinopharm COVID-19 vaccines, which have been conducted in five Arab countries since the summer of 2020, show an efficacy of 78.89 percent on people aged 18 and above, the company executives said during a seminar about vaccine development held in Shanghai on Thursday.

The clinical trials also show a 100 percent protection against severe illness and hospitalization of COVID-19 patients, Zhang Yuntao, vice president and chief scientist of Sinopharm China National Biotec Group (CNBG), a subsidiary of Sinopharm, said during the seminar. 

Zhang announced that the trials, carried out in Adu Dhabi, Sharjah, Bahrain, Egypt and Jordan, with the joint efforts of local scientists and volunteers, covered some 45,000 participants from 125 countries. 

In Adu Dhabi, for instance, 27,362 people have received the first dose of the Sinopharm inactivated vaccine since the trial started in July 2020, with 26,537 of them having received the second dose, according to Zhang. 

At the end of 2020, the United Arab Emirates (UAE) became the first country in the world to offer Chinese COVID-19 vaccines to all its citizens and residents for free. The country now has more than 70 percent of its population vaccinated, making it the second most vaccinated country in the world, according to the UAE Ambassador to China, Ali Obaid Al Dhaheri.

"People in UAE have great trust in Sinopharm's vaccine and highly accept it," Al Dhaheri told the Global Times on Thursday, adding that the majority UAE residents got the Sinopharm vaccines.

The trust partly comes from the efficacy of the vaccine. In the UAE, a recent study by the national immunization program showed that the vaccinated population "are 93 percent less likely to be hospitalized due to COVID-19 compared to the unvaccinated population," Nawal Al Kaabi, chairwoman of UAE's national COVID-19 clinical management committee and participant in the trials, said in a video conference during the seminar.

Trial participant and researcher, Manaf Al Qahtani, also a member of Bahrain's national medical taskforce against the COVID-19, introduced the local situation of the Phase III trials of the Sinopharm vaccine at the seminar by videoconference. The clinical trial involved 7,755 participants in Bahrain, he said.

"I'm glad to say that our results are encouraging," Al Qahtani noted, saying the inoculation resulted in an "overall reduction in mortality and mobility" of the coronavirus, and the side effects are mainly minor. "The most commonly reported side effect was pain on the side of the injection," he added.



No comments

Thank you for reaching out to us. We are happy to receive your opinion and request. If you are need advert or sponsored post, We’re excited you’re considering advertising or sponsoring a post on our blog. Your support is what keeps us going. With the current trend, it’s very obvious content marketing is the way to go. Banner advertising and trying to get customers through Google Adwords may get you customers but it has been proven beyond doubt that Content Marketing has more lasting benefits.
We offer majorly two types of advertising:
1. Sponsored Posts: If you are really interested in publishing a sponsored post or a press release, video content, advertorial or any other kind of sponsored post, then you are at the right place.
WHAT KIND OF SPONSORED POSTS DO WE ACCEPT?
Generally, a sponsored post can be any of the following:
Press release
Advertorial
Video content
Article
Interview
This kind of post is usually written to promote you or your business. However, we do prefer posts that naturally flow with the site’s general content. This means we can also promote artists, songs, cosmetic products and things that you love of all products or services.
DURATION & BONUSES
Every sponsored article will remain live on the site as long as this website exists. The duration is indefinite! Again, we will share your post on our social media channels and our email subscribers too will get to read your article. You’re exposing your article to our: Twitter followers, Facebook fans and other social networks.

We will also try as much as possible to optimize your post for search engines as well.

Submission of Materials : Sponsored post should be well written in English language and all materials must be delivered via electronic medium. All sponsored posts must be delivered via electronic version, either on disk or e-mail on Microsoft Word unless otherwise noted.
PRICING
The price largely depends on if you’re writing the content or we’re to do that. But if your are writing the content, it is $60 per article.

2. Banner Advertising: We also offer banner advertising in various sizes and of course, our prices are flexible. you may choose to for the weekly rate or simply buy your desired number of impressions.

Technical Details And Pricing
Banner Size 300 X 250 pixels : Appears on the home page and below all pages on the site.
Banner Size 728 X 90 pixels: Appears on the top right Corner of the homepage and all pages on the site.
Large rectangle Banner Size (336x280) : Appears on the home page and below all pages on the site.
Small square (200x200) : Appears on the right side of the home page and all pages on the site.
Half page (300x600) : Appears on the right side of the home page and all pages on the site.
Portrait (300x1050) : Appears on the right side of the home page and all pages on the site.
Billboard (970x250) : Appears on the home page.

Submission of Materials : Banner ads can be in jpeg, jpg and gif format. All materials must be deliverd via electronic medium. All ads must be delivered via electronic version, either on disk or e-mail in the ordered pixel dimensions unless otherwise noted.
For advertising offers, send an email with your name,company, website, country and advert or sponsored post you want to appear on our website to omodjk(at)gmail(dot)com

Normally, we should respond within 48 hours.

Sponsored Partner's Advertisement